MB Financial Bank - Trust Department’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-38
Closed -$2K 433
2018
Q1
$2K Buy
+38
New +$1.89K ﹤0.01% 438

Other funds holding EBS

MB Financial Bank - Trust Department's EBS Position: Q2 2018 in Review

MB Financial Bank - Trust Department sold out of Emergent Biosolutions (EBS) in Q2 2018, closing a stake of 38 shares — an estimated $2K sold.

MB Financial Bank - Trust Department first reported a position in EBS in Q1 2018 and held it in 1 quarter. The position peaked at $2K in Q1 2018. 263 funds tracked by Wall St. Rank hold EBS as of Q2 2018.

  • MB Financial Bank - Trust Department reported no remaining Emergent Biosolutions position as of Q2 2018 after selling out during the quarter.
  • MB Financial Bank - Trust Department sold 38 Emergent Biosolutions shares in Q2 2018, an estimated $2K.
  • MB Financial Bank - Trust Department first reported a position in Emergent Biosolutions in Q1 2018 and held it in 1 quarter.
  • MB Financial Bank - Trust Department's Emergent Biosolutions position peaked at $2K in Q1 2018.
  • 263 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2018.

Based on MB Financial Bank - Trust Department's 13F filing for Q2 2018, filed 12 Jul 2018.